ReviewTherapeutics and clinical risk management2025

Hepatic Safety Considerations in the Use of Ulipristal Acetate for Symptomatic Uterine Fibroids.

Annika Semmler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.